Advisor Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,702
Closed -$377K 453
2016
Q4
$377K Buy
4,702
+1,101
+31% +$87.4K 0.11% 223
2016
Q3
$287K Buy
3,601
+474
+15% +$38.3K 0.1% 268
2016
Q2
$244K Buy
+3,127
New +$223K 0.09% 284
2016
Q1
Sell
-5,243
Closed -$324K 429
2015
Q4
$324K Buy
5,243
+37
+0.7% +$2.33K 0.11% 194
2015
Q3
$328K Sell
5,206
-307
-6% -$21.9K 0.14% 182
2015
Q2
$379K Buy
5,513
+30
+0.5% +$2.17K 0.15% 189
2015
Q1
$359K Sell
5,483
-36
-0.7% -$2.39K 0.15% 187
2014
Q4
$357K Sell
5,519
-204
-4% -$13.1K 0.16% 175
2014
Q3
$344K Sell
5,723
-99
-2% -$6.47K 0.2% 142
2014
Q2
$403K Buy
5,822
+379
+7% +$24.6K 0.2% 144
2014
Q1
$356K Buy
5,443
+93
+2% +$6.05K 0.2% 158
2013
Q4
$331K Buy
5,350
+177
+3% +$10.3K 0.19% 160
2013
Q3
$277K Buy
5,173
+121
+2% +$6.23K 0.2% 163
2013
Q2
$231K Buy
+5,052
New +$219K 0.19% 167

Other funds holding STJ

Advisor Partners's STJ Position: Q1 2017 in Review

Advisor Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,702 shares — an estimated $377K sold.

Advisor Partners first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $403K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Advisor Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Advisor Partners sold 4,702 St Jude Medical shares in Q1 2017, an estimated $377K.
  • Advisor Partners first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Advisor Partners's St Jude Medical position peaked at $403K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Advisor Partners's 13F filing for Q1 2017, filed 28 Apr 2017.